The following individuals serve on the scientific advisory board of our parent company, Cancer Communications, Inc. Our advisors' institutional affiliations are listed for informational purposes only. Unless otherwise stated, all opinions expressed in our Moss Reports, weekly newsletter and other publications remain those of our company and are not necessarily those of our advisors or of their affiliated institutions.

Keith I. Block, MD, is medical-scientific director of the Block Center for Integrative Cancer Treatment, in Evanston , IL. He is a member of the National Cancer Institute's PDQ Cancer Complementary & Alternative Medicine (CAM) Editorial Board in Bethesda, MD, and director of Integrative Medical Education at the College of Medicine at the University of Illinois, Chicago. In addition, he is editor-in-chief of the peer-reviewed journal Integrative Cancer Therapies, published by SAGE Science Press and indexed in MEDLINE and Index Medicus. In collaboration with the University of Illinois and with other university facilities in the US and Israel, Dr. Block conducts research in the clinical value of nutrition and in the use of natural medicines in cancer treatment. Dr. Block is a graduate of the University of Miami School of Medicine. After completing a medical residency at Illinois Masonic Medical Center in Chicago, he undertook post-graduate training in nutritional oncology and enteral and parenteral nutrition. He is the author of more than 50 PubMed-listed scientific articles and has contributed to the published works of other medical and science professionals as well.

D. Barry Boyd, MD, is a board-certified medical oncologist at Integrative Oncology, LLC, and Greenwich Hospital, Greenwich, CT. Dr. Boyd completed his undergraduate studies in evolutionary biology and systematics at Cornell University, did a year of research at Memorial Sloan Kettering Cancer Center and enrolled in the Institute for Human Nutrition, studying early nutritional influences on human development and the role of nutritional deficiency on the immune response. He then entered Cornell Medical School, did his internship and residency in internal medicine at the New York Hospital and Memorial Sloan-Kettering Cancer Center and completed a fellowship in hematology-oncology at Cornell Medical Center. He has been an assistant professor of medicine at the Cornell-Weill Medical School and the New York-Presbyterian Hospital. He is presently an affiliate member of the Yale Cancer Center, New Haven, CT.

Kenneth A. Conklin, MD, PhD, is a clinical professor at the David Geffen School of Medicine of the University of California, Los Angeles, California
(UCLA) and a member of the Jonsson Comprehensive Cancer Center at UCLA, where he practices integrative oncology. Dr. Conklin received his PhD in Pharmacology from the University of Hawaii in 1971 and his MD from UCLA in 1974. Following the completion of an anesthesiology residency in 1977, he joined the faculty of the Department of Anesthesiology at UCLA where he served as the director of Obstetric Anesthesia until 1997. He completed the Medical Acupuncture for Physicians course in 1997 and began his practice of integrative oncology at UCLA that year. Dr. Conklin has published extensively. His most recent review articles pertain to the use of acupuncture for the cancer patient and the use of nutritional supplements during chemotherapy. Dr.
Conklin serves as a reviewer for the journal Nutrition and Cancer and as a consultant to the National Center for Complementary and Alternative Medicine (NCCAM).

Jeanne A. Drisko, MD, is Riordan Professor of Orthomolecular Medicine and Research, University of Kansas Medical Center, Kansas City, KS. She has been instrumental in developing research projects in the area of CAM therapies and plays an active role in education of medical students, nursing students, residents, and practicing physicians. Dr. Drisko is vice president and program director of the American College of Advancement in Medicine (ACAM). She is also principal investigator of a randomized controlled trial at the University of Kansas evaluating the safety and efficacy of adding antioxidants, including vitamin C, to chemotherapy in newly diagnosed ovarian cancer.

James A. Duke, PhD, retired as an economic botanist from United States Department of Agriculture (USDA) in 1995. "Jim" Duke received his doctorate in botany (1961) from the University of North Carolina. Following military service, he undertook postdoctoral studies at Washington University and Missouri Botanical Garden in St. Louis, Missouri. During his formative years, Duke lived with various ethnic groups in Colombia and Panama, closely observing their deep dependence on forest products. Between 1978 and 1982 he directed the USDA's cooperative Cancer Screening Program, which was funded by the National Cancer Institute. He wrote a definitive database on medicinal herbs. An indefatigable writer, he is author of a dozen scholarly and popular books including The Green Pharmacy, and Peterson's Field Guide to Medicinal Plants and Herbs, as well as hundreds of articles. Jim Duke is widely considered the world's foremost authority on healing herbs.

Samuel S. Epstein, MD, is professor emeritus of Environmental and Occupational Medicine at the University of Illinois School of Public Health, and Chairman of the Cancer Prevention Coalition. He has published 260+ peer reviewed articles, and authored or co-authored 11 books including the prize-winning The Politics of Cancer; the Safe Shopper's Bible; The Breast Cancer Prevention Program; How to Avoid Cancer from Cosmetics and Personal Care Products and Cancer-Gate: How to Win the Losing Cancer War (2005). Dr. Epstein is an internationally recognized authority on avoidable causes of cancer, particularly unknowing exposures to industrial carcinogens in air, water, the workplace, and consumer products. He was founder of the Environmental Mutagen Society; President of the Society for Occupational and Environmental Health; President of the Rachel Carson Council; and is an advisor to many environmental groups. His numerous honors include the Society of Toxicology Achievement Award; the National Wildlife Federation Conservancy Award; the Environmental Justice Award; the Right Livelihood Award ("Alternative Nobel Prize"); and the Albert Schweitzer Golden Grand Medal for Humanitarianism from the Polish Academy of Medicine (2005).

Joel M. Evans, MD, is a board-certified OB/GYN with a special interest in women's cancers. He is founder and director of The Center for Women's Health, Darien, CT, is assistant clinical professor, Albert Einstein College of Medicine and the College of Physicians and Surgeons of Columbia University, New York, NY. He is on the faculty of the CancerGuides Program of the Center for Mind-Body Medicine, Washington, DC.

Mitchell L. Gaynor, MD, founder and director of Gaynor Integrative Oncology, New York, NY, is a senior medical oncology consultant at The Strang Cancer Prevention Center, NY, as well as assistant clinical professor of Medicine at the Weill Medical College of Cornell University. He is the author of The Healing Power of Sound and Healing Essence. Dr. Gaynor has incorporated visualization, guided imagery and meditation into his medical practice.

Johan Haux, MD, PhD, is a board-certified medical oncologist in the Department of Medicine and Surgery, KSS, Skoevde, Sweden. A graduate of Lund University, Dr. Haux was formerly at the Norwegian University of Science and Technology, Trondheim. He has written on such topics as digitalis, cardiac glycosides, Coley's toxins, cytokines, in relation to cancer.

David J. Hess, PhD, is professor and formerly chairperson of the Department of Science and Technology Studies, Rensselaer Polytechnic Institute, Troy, NY, the oldest technical university in the English-speaking world. He holds a bachelor's degree in economics from Harvard University and a master's and doctorate in anthropology from Cornell University. He is the recipient of two Fulbright fellowships, a Social Science Research Council fellowship, and the Diana Forsythe Prize, and he has been principal investigator on multiple National Science Foundation grants. Dr. Hess is the author of a dozen books on anthropology, social and policy studies of science, technology, and medicine, including Can Bacteria Cause Cancer? Alternative Medicine Confronts Big Science (New York University Press, 1997) and Evaluating Alternative Cancer Therapies: A Guide to the Science and Politics of an Emerging Medical Field (Rutgers University Press, 1999).

Michael Janson, MD, a board-certified internist, is past-president of both the American College for Advancement in Medicine (ACAM) and the American Preventive Medical Association (APMA). He founded and directed the first complementary-alternative medical center in New England, in Cambridge, Massachusetts in 1976. One of the best-known holistic physicians in the US, he is editor of the Healthy Living Newsletter and author of Dr. Janson's New Vitamin Revolution (Penguin 2000) and currently practices medicine in Florida, Massachusetts and New Hampshire.

Douglas Kelly, MD, is a board-certified radiation oncologist at the Cancer Treatment Centers of America (CTCA), Tulsa, OK. A Canadian, he received his medical degree from McGill University, Montreal, and completed his residency in radiation oncology at the Ottawa Regional Cancer Center in Ottawa, Ontario. Dr. Kelly has a particular interest in high dose rate (HDR) breast brachytherapy and MammoSite radiation therapy.

Giancarlo Pizza, MD, and Caterina de Vinci, MD, are both at the Immunodiagnosis and Immunotherapy Unit, 1st Division of Urology, S. Orsola-Malpighi Hospital, a division of the University of Bologna. Dr. Pizza is currently President of the Medical Council of the Province of Bologna, Emilia-Romagna Region. Dr. Pizza is also president of the International Society of Transfer Factor. He has been a visiting scholar at the NIH and Mt. Sinai Hospital (NY), among other institutions, and has been Italian coordinator of several US National Cancer Institute clinical trials. He is the author of 69 PubMed-listed articles, 33 of them with Dr. de Vinci.

Azra Raza, MD, is chairperson of the Division of Hematology and Oncology at the UMass Memorial Medical Center, and professor of medicine at the University of Massachusetts Medical School, both in Worcester, MA. She was formerly a professor of medicine and director of the Section of Myeloid Diseases and MDS Center at Rush-Presbyterian-St. Luke's Medical Center in Chicago. Dr. Raza is a world expert on the research and treatment of myelodysplasia and acute myeloid leukemia, as well as other kinds of cancer. A graduate of Dow Medical College, Karachi, Pakistan, she did a post-doctoral fellowship at the Roswell Park Memorial Institute, Buffalo, NY, where she eventually led the section on Cell Biology. Dr. Raza has authored more than 200 full-length papers, 13 book chapters, 470 abstracts, and edited a book on myelodysplastic syndromes and secondary leukemias. She also serves on numerous national and international panels as a reviewer, consultant and advisor on the subject.

Susan Sencer, MD, is medical director of hematology and oncology, Children's Hospitals and Clinics, Minneapolis, MN. An expert on pediatric cancer, she is director of Integrative Cancer Care at the hospital, where she guides the clinical, research, programming, education, etc. of the integrative medical hematology/oncology specialty area, and provides pediatric hematology/oncology medical services.

Leanna J. Standish, PhD, ND, is a senior research scientist, and former director of the Bastyr University Research Institute (Seattle). At Bastyr, she was the AIDS Research Center principal investigator and director of the University Health Clinic hepatitis C program. Trained at the Downstate Medical Center in New York and the University of Massachusetts, Dr. Standish received her neuroscience doctoral degree in 1978 and was a Fellow at the Yerkes Primate Research Center at Emory University in 1979-1980. From 1980 to 1984, she codirected Smith College's neuroscience program. She then served two years as a visiting scientist/senior fellow in the University of Washington's Department of Physiology and Biophysics. Dr. Standish has served on the Advisory Council for NIH's National Center for Complementary and Alternative Medicine and the NCI Cancer Advisory Panel for Complementary and Alternative Medicine. In addition to her scientific credentials, she is a licensed naturopathic physician and acupuncturist. In her clinical practice, she specializes in complementary care for cancer, AIDS, hepatitis C and neurological diseases. She is co-author of AIDS and Complementary & Alternative Medicine: Current Science and Practice (Churchill-Livingstone, 2002) as well as two dozen PubMed-listed journal articles.